Literature DB >> 2303452

Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B.

C Peters1, B Schmidt, W Rommerskirch, K Rupp, M Zühlsdorf, M Vingron, H E Meyer, R Pohlmann, K von Figura.   

Abstract

A 2.2-kilobase cDNA clone for human arylsulfatase B (ASB) and several genomic clones were isolated and sequenced. The deduced amino acid sequence of 533 amino acids contains a 41-amino acid N-terminal signal peptide and a mature polypeptide of 492 amino acid residues. Overexpression of ASB in transfected baby hamster kidney (BHK) cells resulted in up to 68-fold higher ASB activity than in untransfected BHK cells. Pulse-chase labeling showed that ASB was synthesized and secreted as a 64-kDa precursor and processed to a 47-kDa mature form in BHK cells. The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner. The ASB cDNA clone hybridizes to 4.8-, 2.5-, and 1.8-kilobase species of RNA from human fibroblasts. The same pattern was observed in RNA from fibroblasts of three Maroteaux-Lamy patients who were deficient in ASB activity, as well as in RNA from fibroblasts of three patients with multiple sulfatase deficiency, in which all known sulfatases were markedly diminished. Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid sulfatase, human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial degree of similarity suggesting that they arose from a common ancestral gene and are members of an arylsulfatase gene family.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303452

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Escherichia coli K1 aslA contributes to invasion of brain microvascular endothelial cells in vitro and in vivo.

Authors:  J A Hoffman; J L Badger; Y Zhang; S H Huang; K S Kim
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Mucopolysaccharidosis IVA: four new exonic mutations in patients with N-acetylgalactosamine-6-sulfate sulfatase deficiency.

Authors:  S Tomatsu; S Fukuda; A Yamagishi; A Cooper; J F Wraith; T Hori; Z Kato; N Yamada; K Isogai; K Sukegawa; N Kondo; Y Suzuki; N Shimozawa; T Orii
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

3.  Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients.

Authors:  T Litjens; D A Brooks; C Peters; G J Gibson; J J Hopwood
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

Review 4.  Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment.

Authors:  Benjamin W Redan; Kimberly K Buhman; Janet A Novotny; Mario G Ferruzzi
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

5.  Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients.

Authors:  M F G Petry; K Nonemacher; J C Sebben; I V D Schwartz; A C M Azevedo; M G Burin; A R de Rezende; C A Kim; R Giugliani; S Leistner-Segal
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Four monoclonal antibodies inhibit the recognition of arylsulphatase A by the lysosomal enzyme phosphotransferase.

Authors:  H J Sommerlade; A Hille-Rehfeld; K von Figura; V Gieselmann
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

Review 7.  Chondroitin sulfate/dermatan sulfate sulfatases from mammals and bacteria.

Authors:  Shumin Wang; Kazuyuki Sugahara; Fuchuan Li
Journal:  Glycoconj J       Date:  2016-08-15       Impact factor: 2.916

8.  Human liver N-acetylgalactosamine 6-sulphatase. Purification and characterization.

Authors:  J Bielicki; J J Hopwood
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

9.  Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients.

Authors:  D A Brooks; P A McCourt; G J Gibson; L J Ashton; M Shutter; J J Hopwood
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.